Efavirenz
- Product NDC
- 70518-2962
- 11-digit product format
- 705182962
- Labeler code
- 70518
- Product ID
- 70518-2962_dd2b3672-8148-7c82-e053-2a95a90a3e71
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Efavirenz
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA204766
- Marketing category
- ANDA
- Marketing start
- 2020-12-08
- Marketing end
- 0000-00-00
- Substance
- EFAVIRENZ
- Active strength
- 600 mg/1
- Pharmacologic classes
- Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2962-0 | 70518296200 | 30 TABLET, FILM COATED in 1 BLISTER PACK (70518-2962-0) | 2020-12-08 | 0000-00-00 | No | No | Current |